NAION is a serious condition characterized by sudden, painless vision loss in one eye, often due to insufficient blood supply to the optic nerve. Clinical findings suggest a potential correlation with certain GLP-1 medications, warranting immediate medical and legal review for affected patients.
Research focuses on how GLP-1 receptor agonists might impact ocular blood flow and contribute to optic disc swelling, a precursor to NAION. Documenting prescription dates and symptom onset is essential for establishing a clear case timeline for pharmaceutical accountability.
Key Clinical Findings
30%
Increased NAION Risk
80%
Report Sudden Vision Loss
15+
Active Clinical Studies
Review Your Case Confidentially
If you experienced sudden vision changes while taking a GLP-1 medication, understand how study criteria apply to your diagnosis. Your initial case evaluation is completely confidential and costs nothing unless we secure compensation.